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Introduction. Dermatoﬁbrosarcoma Protuberans (DFSP) is a rare cutaneous tumour of low/intermediate malignant potential,
which occasionally arises on the vulva. Historically, the treatment has been wide local excision (WLE). Mohs micrographic
surgery (MMS) is now recommended to ensure precise margin control. MMS to treat DFSP of the trunk and extremities is well
documented. However, no report to date has described its use in vulval DFSP. Case History. A 39 year old woman presented with
a longstanding nodule in the left labium majus. Histology after surgical removal showed an incompletely excised DFSP. MMS was
undertaken with primary closure of the defect. Three years following treatment there is no evidence of recurrence. Discussion.T h e
local recurrence rate of DFSP after WLE ranges from 0–75%. Finger-like projections from DFSP into surrounding tissue often
results in incomplete excision. Representative vertical sections used in WLE assess less than 1% of the total tumour margin. MMS
uses systematic horizontal sectioning. 100% of the tumour margin is microscopically examined. MMS is now advocated to ensure
precise margin control.
Copyright © 2009 K. Doufekas et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Dermatoﬁbrosarcoma protuberans (DFSP) is a rare cuta-
neous tumour of low/ intermediate malignant potential,
which occasionally arises in the vulva. Historically, the
treatment has been wide local excision (WLE). However,
local recurrence rates after WLE are high [1]. Microscopic
projections of the tumour into surrounding tissue often
extend beyond the central nodule, resulting in incomplete
excision [2, 3].
Mohs Micrographic Surgery (MMS) oﬀers an alternative
therapeutic approach. MMS allows mapping of the extend
of DFSP with microscopic examination of its deep and
lateral margins. 100% of the tumour margin is examined.
The microscopic tumour projections into surrounding tissue
are reliably identiﬁed and excised. Favourable outcomes are
reportedwithpreservationoftissueandalowrecurrencerate
[1].
MMS to treat DFSP of the trunk and extremities is well
documented [1]. However, no report to date has described
its use in DFSP of the vulva.
2. Case History
A-39-yearoldwomanpresentedwithalongstandingpainless
nodule in the left labium majus. Histology after surgical
removal showed an incompletely excised DFSP. Chest X-Ray
showed no evidence of metastasis.
Further management involved a multidisciplinary team,
consisting of a dermatologist, gynaecological oncologist, and
histopathologist.
A residual 10–15mm nodule was ﬁrst debulked under
local anaesthetic. MMS was then undertaken. A highly
specialized and accurate protocol of surgical technique were
followed.
Anatomic orientation of the specimen was deﬁned and
drawn onto a map. The specimen was then sliced so that
deep and lateral margins lay in the same plane. Horizontal
frozen sections were stained with haematoxylin and eosin
and examined microscopically to provide a complete 360
degree view of the tumour margins. With MMS the micro-
scopic projections into surrounding tissue can be identiﬁed.
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anatomic map to guide excision. A further tissue layer is
removed and the same meticulous procedure is followed
until microscopic examination shows no residual tumour.
In our patient the tumour was completely removed after
one stage of MMS. The defect was repaired with primary
closure.Threeyearsfollowingtreatment,thereisnoevidence
of recurrence.
3. Discussion
3.1. Epidemiology. DFSP is a rare neoplasm accounting for
0.1% of all malignancies [4]. It typically occurs between the
ages of 20 and 40 years, frequently arising on the trunk. The
head and extremities are less commonly involved.
DFSP of the clitoris and vulva are rare. DFSP of the vulva
typically arises in the left labium majus [5]. The reason for
this predilection is unclear.
3.2. Clinical Features. The tumour often presents as a solid,
protuberant nodule. Due to its indolent nature, it often
escapes detection in the early stages. Pain and ulceration may
occur with tumours in an accelerated growth phase [3].
Aggressive local growth is characteristic. MRI can iden-
tify the extent of the tumour and its relation to adjacent
structures [4].
Lymphatic spread of DFSP is rare [2]. Metastatic DFSP
is uncommon, occurring in less than 6% of cases. Metastases
typically involve the lungs and bones [3].
3.3. Pathology. The tumour most probably arises from a
stem cell within the dermis. Local growth exhibits ﬁngerlike
projections into surrounding tissue. Subsequently, it can
invade the subcutaneous tissue, underlying fasciae, muscle
and bone [3].
Correct histological diagnosis can be problematic as it is
often diﬃcult to distinguish DFSP from other ﬁbrohistio-
cytic neoplasms [3]. Comprehensive immunohistochemical
studies aid the diagnosis.
Histology typically shows elongated ﬁbroblasts with
small nuclei arranged in a “storiform” pattern. Compared
to ﬁbrous histiocytomas DFSP displays a more uniform
appearance with little nuclear pleomorphism and low to
moderate mitotic activity. Absence of necrosis and immuno-
histochemical staining for CD34 diﬀerentiate DFSP from
ﬁbrous histiocytomas [3].
3.4.Treatment. Historically,thetreatmentforDFSPhasbeen
wide local excision (WLE) of both primary and recurrent
lesions.
The local recurrence rate of DFSP after WLE ranges
from 0%–21% for trunk sites and 50%–75% for head and
neck sites [1]. In the vulva the local recurrence rate after
WLE ranges from 20%–49% [2]. Microscopic projections
of the tumour beyond the central nodule often result in
incomplete excision. Representative vertical sections used in
WLE assess less than 1% of the total tumour margin. There
is hence an increased risk of potentially missing these narrow
projections, which may lead to tumour recurrence.
MMS uses systematic horizontal sectioning with 100%
of the tumour margin being microscopically examined. This
increases the likelihood of any tumour projections being
detected.
Since MMS allows for accurate margin control, maxi-
mum preservation of healthy tissue with complete excision
can be achieved. It, therefore, leaves the smallest post
surgicaldefectandminimisesrecurrence.Nearly75%ofsuch
wounds can be managed with primary closure.
Tissue conservation was important in our case to pre-
serve function, with the DFSP being close to the clitoris.
Wide local excision with 3cm margins as previously recom-
mended [2] may have been unduly mutilating.
MMS is now advocated to ensure precise margin control.
The favorable success rate of MMS compared to WLE in
patients with DFSP is well documented [1]. Site distribution
for this technique has included head and neck, extremities,
and the clitoris but not the vulva.
The local recurrence rate after the ﬁrst MMS treatment
for all patients with DFSP, has been reported as 7% over a 5-
year period. 5 year cure rates have been reported as 92% for
head and neck sites, 94% for trunk sites and 100% for DFSP
in extremity sites. The 5-year cure rate for all sites was 93%
aftertheﬁrstMMStreatmentand98.5%afterthesecond[1].
Local recurrence after MMS may be related to “skip”
areas of tumour that become separated from the main
tumour mass. However 25% of local-recurrences develop
after 5 years [1]. Long term follow up is recommended.
4. Conclusion
WLE for DFSP of the vulva has previously been described.
MMS for DFSP of the vulva represents, however, a novel
treatment. Treatment outcomes for DFSP at other sites are
uniformly more favorable with MMS when compared with
standard WLE [1]. This case also highlights the utility of
Mohs Surgery in conserving normal tissue.
We, therefore, propose that MMS is considered in all
cases of primary or recurrent DFSP of the vulva.
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